Feasibility study for supporting medication adherence for adults with cystic fibrosis: mixed-methods process evaluation

HIND, Daniel, DRABBLE, Sarah J, ARDEN, Madelynne, MANDEFIELD, Laura, WATERHOUSE, Simon, MAGUIRE, Chin, CANTRILL, Hannah, ROBINSON, Louisa, BEEVER, Daniel, SCOTT, Alex, KEATING, Sam, HUTCHINGS, Marlene, BRADLEY, Judy, NIGHTINGALE, Julia, ALLENBY, Mark I, DEWAR, Jane, WHELAN, Pauline, AINSWORTH, John, WALTERS, Stephen J, WILDMAN, Martin J and O'CATHAIN, Alicia (2020). Feasibility study for supporting medication adherence for adults with cystic fibrosis: mixed-methods process evaluation. BMJ Open, 10 (10), e039089.

[img]
Preview
PDF
bmjopen-2020-039089.pdf - Published Version
Creative Commons Attribution.

Download (1MB) | Preview
Open Access URL: https://bmjopen.bmj.com/content/10/10/e039089.info (Published version)
Link to published version:: https://doi.org/10.1136/bmjopen-2020-039089
Related URLs:

    Abstract

    Objectives: To undertake a process evaluation of an adherence support intervention for people with cystic fibrosis (PWCF), to assess its feasibility and acceptability. Setting: Two UK cystic fibrosis (CF) units. Participants: Fourteen adult PWCF; three professionals delivering adherence support (‘interventionists’); five multi-disciplinary CF team members. Interventions: Nebuliser with data recording and transfer capability, linked to a software platform, and strategies to support adherence to nebulised treatments facilitated by interventionists over 5 months (± 1 month). Primary and secondary measures: Feasibility and acceptability of the intervention, assessed through semistructured interviews, questionnaires, fidelity assessments and click analytics. Results: Interventionists were complimentary about the intervention and training. Key barriers to intervention feasibility and acceptability were identified. Interventionists had difficulty finding clinic space and time in normal working hours to conduct review visits. As a result, fewer than expected intervention visits were conducted and interviews indicated this may explain low adherence in some intervention arm participants. Adherence levels appeared to be >100% for some patients, due to inaccurate prescription data, particularly in patients with complex treatment regimens. Flatlines in adherence data at the start of the study were linked to device connectivity problems. Content and delivery quality fidelity were 100% and 60%–92%, respectively, indicating that interventionists needed to focus more on intervention ‘active ingredients’ during sessions. Conclusions: The process evaluation led to 14 key changes to intervention procedures to overcome barriers to intervention success. With the identified changes, it is feasible and acceptable to support medication adherence with this intervention. Trial registration number: ISRCTN13076797; Results.

    Item Type: Article
    Additional Information: ** Embargo end date: 27-10-2020 ** From BMJ via Jisc Publications Router ** Licence for this article starting on 27-10-2020: https://creativecommons.org/licenses/by/4.0/ **Journal IDs: eissn 2044-6055 **Article IDs: publisher-id: bmjopen-2020-039089 **History: published_online 27-10-2020; published 10-2020; accepted 29-09-2020; rev-recd 27-07-2020; submitted 06-04-2020
    Uncontrolled Keywords: Respiratory medicine, 1506, 1731, cystic fibrosis, health informatics, clinical trials, statistics & research methods, social medicine, quality in healthcare
    Identification Number: https://doi.org/10.1136/bmjopen-2020-039089
    Page Range: e039089
    SWORD Depositor: Colin Knott
    Depositing User: Colin Knott
    Date Deposited: 29 Oct 2020 17:40
    Last Modified: 17 Mar 2021 21:30
    URI: http://shura.shu.ac.uk/id/eprint/27515

    Actions (login required)

    View Item View Item

    Downloads

    Downloads per month over past year

    View more statistics